Lajos Csincsik1,2, Thomas J MacGillivray3,4, Erin Flynn1,5, Enrico Pellegrini3,6, Giorgos Papanastasiou4, Neda Barzegar-Befroei2, Adrienne Csutak2,7, Alan C Bird2, Craig W Ritchie8, Tunde Peto1,9, Imre Lengyel1,2. 1. School of Medicine, Dentistry and Biomedical Science, Queen's University, Belfast, United Kingdom. 2. UCL Institute of Ophthalmology, London, United Kingdom. 3. VAMPIRE Project, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom. 4. Edinburgh Imaging, University of Edinburgh, Edinburgh, United Kingdom. 5. The George Washington University, School of Medicine and Health Sciences, Washington, District of Columbia, USA. 6. OPTOS plc, Dunfermline, United Kingdom. 7. Department of Ophthalmology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. 8. Centre for Dementia Prevention, University of Edinburgh, Edinburgh, United Kingdom. 9. NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL, London, United Kingdom.
Abstract
PURPOSE: To examine whether ultra-widefield (UWF) retinal imaging can identify biomarkers for Alzheimer's disease (AD) and its progression. METHODS: Images were taken using a UWF scanning laser ophthalmoscope (Optos P200C AF) to determine phenotypic variations in 59 patients with AD and 48 healthy controls at baseline (BL). All living participants were invited for a follow-up (FU) after 2 years and imaged again (if still able to participate). All participants had blood taken for genotyping at BL. Images were graded for the prevalence of age-related macular degeneration-like pathologies and retinal vascular parameters. Comparison between AD patients and controls was made using the Student t test and the χ2 test. RESULTS: Analysis at BL revealed a significantly higher prevalence of a hard drusen phenotype in the periphery of AD patients (14/55; 25.4%) compared to controls (2/48; 4.2%) [χ2 = 9.9, df = 4, p = 0.04]. A markedly increased drusen number was observed at the 2-year FU in patients with AD compared to controls. There was a significant increase in venular width gradient at BL (zone C: 8.425 × 10-3 ± 2.865 × 10-3 vs. 6.375 × 10-3 ± 1.532 × 10-3, p = 0.008; entire image: 8.235 × 10-3 ± 2.839 × 10-3 vs. 6.050 × 10-3 ± 1.414 × 10-3, p = 0.004) and a significant decrease in arterial fractal dimension in AD at BL (entire image: 1.250 ± 0.086 vs. 1.304 ± 0.089, p = 0.049) with a trend for both at FU. CONCLUSIONS: UWF retinal imaging revealed a significant association between AD and peripheral hard drusen formation and changes to the vasculature beyond the posterior pole, at BL and after clinical progression over 2 years, suggesting that monitoring pathological changes in the peripheral retina might become a valuable tool in AD monitoring. The Author(s). Published by S. Karger AG, Basel.
PURPOSE: To examine whether ultra-widefield (UWF) retinal imaging can identify biomarkers for Alzheimer's disease (AD) and its progression. METHODS: Images were taken using a UWF scanning laser ophthalmoscope (Optos P200CAF) to determine phenotypic variations in 59 patients with AD and 48 healthy controls at baseline (BL). All living participants were invited for a follow-up (FU) after 2 years and imaged again (if still able to participate). All participants had blood taken for genotyping at BL. Images were graded for the prevalence of age-related macular degeneration-like pathologies and retinal vascular parameters. Comparison between ADpatients and controls was made using the Student t test and the χ2 test. RESULTS: Analysis at BL revealed a significantly higher prevalence of a hard drusen phenotype in the periphery of ADpatients (14/55; 25.4%) compared to controls (2/48; 4.2%) [χ2 = 9.9, df = 4, p = 0.04]. A markedly increased drusen number was observed at the 2-year FU in patients with AD compared to controls. There was a significant increase in venular width gradient at BL (zone C: 8.425 × 10-3 ± 2.865 × 10-3 vs. 6.375 × 10-3 ± 1.532 × 10-3, p = 0.008; entire image: 8.235 × 10-3 ± 2.839 × 10-3 vs. 6.050 × 10-3 ± 1.414 × 10-3, p = 0.004) and a significant decrease in arterial fractal dimension in AD at BL (entire image: 1.250 ± 0.086 vs. 1.304 ± 0.089, p = 0.049) with a trend for both at FU. CONCLUSIONS: UWF retinal imaging revealed a significant association between AD and peripheral hard drusen formation and changes to the vasculature beyond the posterior pole, at BL and after clinical progression over 2 years, suggesting that monitoring pathological changes in the peripheral retina might become a valuable tool in AD monitoring. The Author(s). Published by S. Karger AG, Basel.
Authors: F J de Jong; E M C Schrijvers; M K Ikram; P J Koudstaal; P T V M de Jong; A Hofman; J R Vingerling; M M B Breteler Journal: Neurology Date: 2011-02-02 Impact factor: 9.910
Authors: Harald Hampel; Katharina Bürger; Stefan J Teipel; Arun L W Bokde; Henrik Zetterberg; Kaj Blennow Journal: Alzheimers Dement Date: 2007-12-21 Impact factor: 21.566
Authors: Tailoi Chan-Ling; D Scott McLeod; Suzanne Hughes; Louise Baxter; Yi Chu; Takuya Hasegawa; Gerard A Lutty Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: Rachael I Scahill; Jonathan M Schott; John M Stevens; Martin N Rossor; Nick C Fox Journal: Proc Natl Acad Sci U S A Date: 2002-04-02 Impact factor: 11.205
Authors: S Frost; Y Kanagasingam; H Sohrabi; J Vignarajan; P Bourgeat; O Salvado; V Villemagne; C C Rowe; S Lance Macaulay; C Szoeke; K A Ellis; D Ames; C L Masters; S Rainey-Smith; R N Martins Journal: Transl Psychiatry Date: 2013-02-26 Impact factor: 6.222
Authors: Kyungsoo Shin; James E Kent; Chandan Singh; Lynn M Fujimoto; Jinghua Yu; Ye Tian; Wonpil Im; Francesca M Marassi Journal: Proc Natl Acad Sci U S A Date: 2020-07-22 Impact factor: 11.205
Authors: Siegfried K Wagner; Dun Jack Fu; Livia Faes; Xiaoxuan Liu; Josef Huemer; Hagar Khalid; Daniel Ferraz; Edward Korot; Christopher Kelly; Konstantinos Balaskas; Alastair K Denniston; Pearse A Keane Journal: Transl Vis Sci Technol Date: 2020-02-12 Impact factor: 3.283
Authors: Ivan Koychev; Jennifer Lawson; Tharani Chessell; Clare Mackay; Roger Gunn; Barbara Sahakian; James B Rowe; Alan J Thomas; Lynn Rochester; Dennis Chan; Brian Tom; Paresh Malhotra; Clive Ballard; Iain Chessell; Craig W Ritchie; Vanessa Raymont; Iracema Leroi; Imre Lengyel; Matt Murray; David L Thomas; John Gallacher; Simon Lovestone Journal: BMJ Open Date: 2019-03-23 Impact factor: 2.692
Authors: Ian F Harrison; Rozalind Whitaker; Pietro Maria Bertelli; James M O'Callaghan; Lajos Csincsik; Martina Bocchetta; Da Ma; Alice Fisher; Zeshan Ahmed; Tracey K Murray; Michael J O'Neill; Jonathan D Rohrer; Mark F Lythgoe; Imre Lengyel Journal: Acta Neuropathol Commun Date: 2019-01-07 Impact factor: 7.801
Authors: Haoshen Shi; Yosef Koronyo; Altan Rentsendorj; Giovanna C Regis; Julia Sheyn; Dieu-Trang Fuchs; Andrei A Kramerov; Alexander V Ljubimov; Oana M Dumitrascu; Anthony R Rodriguez; Ernesto Barron; David R Hinton; Keith L Black; Carol A Miller; Nazanin Mirzaei; Maya Koronyo-Hamaoui Journal: Acta Neuropathol Date: 2020-02-10 Impact factor: 17.088